MMIC expands to Clayton

MIPS initiative the Medicine Manufacturing Innovation Centre (MMIC) will open a second node in Clayton as part of a $16.12 million investment through the Victorian Higher Education State Investment Fund (VHESIF) to support smart manufacturing, and research and development commercialisation at Monash.
The investment will deliver far-reaching benefits to the Victorian community by enhancing research commercialisation, supporting the creation of future industries and jobs, accelerating the attraction of international investment, and building access to global supply chains.
The expansion to Clayton will allow the scaleup of medicine manufacturing capability, and support for clinical trials and growth of exports and jobs.
The MMIC has a focus on growing exports of medicines manufactured in Victoria and supports pharmaceutical manufacturers and allied industries by facilitating the optimisation of processes, current and new product development and building supply of highly skilled, industry- ready, workforce candidates.
It provides clients with access to world-class infrastructure and a multidisciplinary team to deliver economic impact and competitiveness to the state, ensuring that Victorian manufacturers remain leaders in a global market through collaboration and the use of creative and disruptive innovation.
President and Vice-Chancellor Professor Margaret Gardner AC said, "Monash University is pleased to receive $16.12 million through the VHESIF to drive commercial and entrepreneurial activity across the Monash Technology Precinct."
The funding will enable the MMIC to greatly enhance process optimisation and product development, and advance medicine manufacturing and clinical trials through the establishment of a new node at Clayton campus.
Director of MMIC Professor Michelle McIntosh said,
We are excited that the expansion of MMIC will allow us to engage with more industry partners, and continue our workforce development program for the medical technology and pharmaceutical sector.
The MMIC was one of three projects funded by the investment.